nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR5—pituitary gland—hypothyroidism	0.0353	0.162	CbGeAlD
Pasireotide—SSTR3—pituitary gland—hypothyroidism	0.0338	0.155	CbGeAlD
Pasireotide—SSTR1—pituitary gland—hypothyroidism	0.0267	0.123	CbGeAlD
Pasireotide—SSTR5—cerebellum—hypothyroidism	0.0241	0.11	CbGeAlD
Pasireotide—SSTR3—cerebellum—hypothyroidism	0.0231	0.106	CbGeAlD
Pasireotide—SSTR2—pituitary gland—hypothyroidism	0.0227	0.104	CbGeAlD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0212	0.0457	CbGpPWpGaD
Pasireotide—SSTR1—liver—hypothyroidism	0.0187	0.0856	CbGeAlD
Pasireotide—SSTR1—cerebellum—hypothyroidism	0.0182	0.0836	CbGeAlD
Pasireotide—SSTR3—Peptide GPCRs—TSHR—hypothyroidism	0.0175	0.0376	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0173	0.0374	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—TSHR—hypothyroidism	0.0167	0.0361	CbGpPWpGaD
Pasireotide—SSTR2—cerebellum—hypothyroidism	0.0155	0.0711	CbGeAlD
Pasireotide—SSTR5—Peptide GPCRs—TSHR—hypothyroidism	0.0148	0.032	CbGpPWpGaD
Pasireotide—Hypertension—Liothyronine—hypothyroidism	0.0145	0.0455	CcSEcCtD
Pasireotide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.014	0.0441	CcSEcCtD
Pasireotide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.014	0.0441	CcSEcCtD
Pasireotide—SSTR2—Peptide GPCRs—TSHR—hypothyroidism	0.0137	0.0295	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0136	0.0294	CbGpPWpGaD
Pasireotide—Hypotension—Liothyronine—hypothyroidism	0.0128	0.0402	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0112	0.0241	CbGpPWpGaD
Pasireotide—Hypoglycaemia—Liotrix—hypothyroidism	0.0103	0.0324	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00921	0.0199	CbGpPWpGaD
Pasireotide—Hypokalaemia—Liotrix—hypothyroidism	0.00916	0.0288	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00883	0.019	CbGpPWpGaD
Pasireotide—Abdominal distension—Liotrix—hypothyroidism	0.00876	0.0275	CcSEcCtD
Pasireotide—Alopecia—Levothyroxine—hypothyroidism	0.00837	0.0263	CcSEcCtD
Pasireotide—Alopecia—Dextrothyroxine—hypothyroidism	0.00837	0.0263	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00783	0.0169	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00723	0.0156	CbGpPWpGaD
Pasireotide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00702	0.022	CcSEcCtD
Pasireotide—Arthralgia—Levothyroxine—hypothyroidism	0.00702	0.022	CcSEcCtD
Pasireotide—Anxiety—Levothyroxine—hypothyroidism	0.00699	0.022	CcSEcCtD
Pasireotide—Anxiety—Dextrothyroxine—hypothyroidism	0.00699	0.022	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00618	0.0133	CbGpPWpGaD
Pasireotide—Alopecia—Liotrix—hypothyroidism	0.00616	0.0193	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00613	0.0193	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00613	0.0193	CcSEcCtD
Pasireotide—Insomnia—Dextrothyroxine—hypothyroidism	0.00609	0.0191	CcSEcCtD
Pasireotide—Insomnia—Levothyroxine—hypothyroidism	0.00609	0.0191	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00592	0.0128	CbGpPWpGaD
Pasireotide—Fatigue—Levothyroxine—hypothyroidism	0.0058	0.0182	CcSEcCtD
Pasireotide—Fatigue—Dextrothyroxine—hypothyroidism	0.0058	0.0182	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00551	0.0119	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00551	0.0119	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0055	0.0173	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0055	0.0173	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00543	0.0117	CbGpPWpGaD
Pasireotide—Abdominal pain—Levothyroxine—hypothyroidism	0.00532	0.0167	CcSEcCtD
Pasireotide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00532	0.0167	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00528	0.0114	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00528	0.0114	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00525	0.0113	CbGpPWpGaD
Pasireotide—Hypertension—Liotrix—hypothyroidism	0.00524	0.0164	CcSEcCtD
Pasireotide—Arthralgia—Liotrix—hypothyroidism	0.00516	0.0162	CcSEcCtD
Pasireotide—Anxiety—Liotrix—hypothyroidism	0.00515	0.0162	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00485	0.0105	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00484	0.0104	CbGpPWpGaD
Pasireotide—Asthenia—Dextrothyroxine—hypothyroidism	0.00483	0.0152	CcSEcCtD
Pasireotide—Asthenia—Levothyroxine—hypothyroidism	0.00483	0.0152	CcSEcCtD
Pasireotide—Pruritus—Levothyroxine—hypothyroidism	0.00476	0.015	CcSEcCtD
Pasireotide—Pruritus—Dextrothyroxine—hypothyroidism	0.00476	0.015	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—TRH—hypothyroidism	0.0047	0.0101	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00468	0.0101	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00468	0.0101	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00464	0.01	CbGpPWpGaD
Pasireotide—Hypotension—Liotrix—hypothyroidism	0.00462	0.0145	CcSEcCtD
Pasireotide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0046	0.0145	CcSEcCtD
Pasireotide—Diarrhoea—Levothyroxine—hypothyroidism	0.0046	0.0145	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—TRH—hypothyroidism	0.00451	0.00973	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00451	0.0142	CcSEcCtD
Pasireotide—Insomnia—Liotrix—hypothyroidism	0.00448	0.0141	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00445	0.00959	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00432	0.00932	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00432	0.00932	CbGpPWpGaD
Pasireotide—Decreased appetite—Liotrix—hypothyroidism	0.0043	0.0135	CcSEcCtD
Pasireotide—Vomiting—Dextrothyroxine—hypothyroidism	0.00428	0.0134	CcSEcCtD
Pasireotide—Vomiting—Levothyroxine—hypothyroidism	0.00428	0.0134	CcSEcCtD
Pasireotide—Fatigue—Liotrix—hypothyroidism	0.00427	0.0134	CcSEcCtD
Pasireotide—Constipation—Liotrix—hypothyroidism	0.00423	0.0133	CcSEcCtD
Pasireotide—Headache—Levothyroxine—hypothyroidism	0.00422	0.0132	CcSEcCtD
Pasireotide—Headache—Dextrothyroxine—hypothyroidism	0.00422	0.0132	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—TSHB—hypothyroidism	0.00419	0.00904	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—TSHR—hypothyroidism	0.00419	0.00904	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00411	0.00887	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Liotrix—hypothyroidism	0.00405	0.0127	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—TSHB—hypothyroidism	0.00402	0.00867	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—TSHR—hypothyroidism	0.00402	0.00867	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—TRH—hypothyroidism	0.004	0.00863	CbGpPWpGaD
Pasireotide—Nausea—Levothyroxine—hypothyroidism	0.004	0.0126	CcSEcCtD
Pasireotide—Nausea—Dextrothyroxine—hypothyroidism	0.004	0.0126	CcSEcCtD
Pasireotide—Abdominal pain—Liotrix—hypothyroidism	0.00391	0.0123	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—AVP—hypothyroidism	0.0038	0.00819	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—TRH—hypothyroidism	0.00369	0.00796	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—TSHB—hypothyroidism	0.00357	0.00769	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—TSHR—hypothyroidism	0.00357	0.00769	CbGpPWpGaD
Pasireotide—Asthenia—Liotrix—hypothyroidism	0.00355	0.0112	CcSEcCtD
Pasireotide—Pruritus—Liotrix—hypothyroidism	0.0035	0.011	CcSEcCtD
Pasireotide—Diarrhoea—Liotrix—hypothyroidism	0.00339	0.0106	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—TSHB—hypothyroidism	0.00329	0.0071	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—TSHR—hypothyroidism	0.00329	0.0071	CbGpPWpGaD
Pasireotide—Dizziness—Liotrix—hypothyroidism	0.00327	0.0103	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00325	0.007	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00322	0.00693	CbGpPWpGaD
Pasireotide—Vomiting—Liotrix—hypothyroidism	0.00315	0.00988	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00311	0.00671	CbGpPWpGaD
Pasireotide—Headache—Liotrix—hypothyroidism	0.0031	0.00974	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00308	0.00665	CbGpPWpGaD
Pasireotide—Nausea—Liotrix—hypothyroidism	0.00294	0.00923	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00276	0.00595	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00273	0.0059	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—POMC—hypothyroidism	0.00271	0.00585	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TRH—hypothyroidism	0.00266	0.00573	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—POMC—hypothyroidism	0.0026	0.00561	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TRH—hypothyroidism	0.00255	0.0055	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00255	0.00549	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00252	0.00544	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—AVP—hypothyroidism	0.00247	0.00533	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TRH—hypothyroidism	0.00241	0.00521	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TSHR—hypothyroidism	0.00237	0.00511	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—TSHB—hypothyroidism	0.00237	0.00511	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—AVP—hypothyroidism	0.00237	0.00511	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TRH—hypothyroidism	0.00231	0.00499	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—POMC—hypothyroidism	0.00231	0.00497	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00227	0.0049	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00227	0.0049	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TRH—hypothyroidism	0.00226	0.00488	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00216	0.00465	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TSHB—hypothyroidism	0.00215	0.00464	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TSHR—hypothyroidism	0.00215	0.00464	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—POMC—hypothyroidism	0.00213	0.00459	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—AVP—hypothyroidism	0.0021	0.00453	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TRH—hypothyroidism	0.00209	0.0045	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00207	0.00446	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TSHB—hypothyroidism	0.00206	0.00445	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TSHR—hypothyroidism	0.00206	0.00445	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TRH—hypothyroidism	0.00205	0.00443	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TSHB—hypothyroidism	0.00201	0.00435	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TSHR—hypothyroidism	0.00201	0.00435	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—AVP—hypothyroidism	0.00194	0.00418	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TRH—hypothyroidism	0.00189	0.00409	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TSHB—hypothyroidism	0.00186	0.00401	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TSHR—hypothyroidism	0.00186	0.00401	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00183	0.00396	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TSHB—hypothyroidism	0.00183	0.00395	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TSHR—hypothyroidism	0.00183	0.00395	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00169	0.00365	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TSHB—hypothyroidism	0.00169	0.00364	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TSHR—hypothyroidism	0.00169	0.00364	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CLTC—hypothyroidism	0.00165	0.00356	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—POMC—hypothyroidism	0.00164	0.00354	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CLTC—hypothyroidism	0.00158	0.00341	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—POMC—hypothyroidism	0.00157	0.0034	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—VAV3—hypothyroidism	0.00145	0.00313	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TRH—hypothyroidism	0.00143	0.00308	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CLTC—hypothyroidism	0.0014	0.00303	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AVP—hypothyroidism	0.0014	0.00301	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—POMC—hypothyroidism	0.0014	0.00301	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—VAV3—hypothyroidism	0.00139	0.003	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TRH—hypothyroidism	0.00137	0.00295	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AVP—hypothyroidism	0.00134	0.00289	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—VAV3—hypothyroidism	0.00132	0.00284	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CLTC—hypothyroidism	0.00129	0.00279	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—POMC—hypothyroidism	0.00129	0.00278	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSHB—hypothyroidism	0.00127	0.00274	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSHR—hypothyroidism	0.00127	0.00274	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AVP—hypothyroidism	0.00127	0.00274	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—VAV3—hypothyroidism	0.00126	0.00272	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—VAV3—hypothyroidism	0.00123	0.00266	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSHB—hypothyroidism	0.00122	0.00263	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSHR—hypothyroidism	0.00122	0.00263	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AVP—hypothyroidism	0.00122	0.00262	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TRH—hypothyroidism	0.00121	0.00262	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AVP—hypothyroidism	0.00119	0.00256	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—VAV3—hypothyroidism	0.00114	0.00245	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SH2B3—hypothyroidism	0.00113	0.00244	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—VAV3—hypothyroidism	0.00112	0.00241	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TRH—hypothyroidism	0.00112	0.00241	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AVP—hypothyroidism	0.0011	0.00236	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SH2B3—hypothyroidism	0.00109	0.00234	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSHR—hypothyroidism	0.00108	0.00233	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSHB—hypothyroidism	0.00108	0.00233	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AVP—hypothyroidism	0.00108	0.00233	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—VAV3—hypothyroidism	0.00103	0.00223	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSHB—hypothyroidism	0.000997	0.00215	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSHR—hypothyroidism	0.000997	0.00215	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AVP—hypothyroidism	0.000995	0.00215	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SH2B3—hypothyroidism	0.000963	0.00208	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—hypothyroidism	0.000928	0.002	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—hypothyroidism	0.00089	0.00192	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SH2B3—hypothyroidism	0.000889	0.00192	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—hypothyroidism	0.000843	0.00182	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PRL—hypothyroidism	0.000841	0.00181	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—hypothyroidism	0.000808	0.00174	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PRL—hypothyroidism	0.000806	0.00174	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—hypothyroidism	0.000789	0.0017	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VAV3—hypothyroidism	0.000778	0.00168	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AVP—hypothyroidism	0.000749	0.00162	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VAV3—hypothyroidism	0.000746	0.00161	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—hypothyroidism	0.000728	0.00157	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AVP—hypothyroidism	0.000718	0.00155	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—hypothyroidism	0.000717	0.00155	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRL—hypothyroidism	0.000715	0.00154	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—hypothyroidism	0.000661	0.00143	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VAV3—hypothyroidism	0.000661	0.00143	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRL—hypothyroidism	0.00066	0.00142	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AVP—hypothyroidism	0.000637	0.00137	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VAV3—hypothyroidism	0.00061	0.00132	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AVP—hypothyroidism	0.000588	0.00127	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—hypothyroidism	0.000498	0.00107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1—hypothyroidism	0.000479	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—hypothyroidism	0.000477	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1—hypothyroidism	0.000459	0.00099	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—hypothyroidism	0.000423	0.000913	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1—hypothyroidism	0.000407	0.000878	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—hypothyroidism	0.000391	0.000843	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1—hypothyroidism	0.000376	0.000811	CbGpPWpGaD
